chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vomiting starting at 9:15 pm on/off through 11:30 pm. Attempted to take pepto at 10:00 pm and promptly threw that up too, had chills during this period, used layers and a heating pad to warm up, was dizzy at 2:40 am on 04/10, lasted into 04/10. Had body aches on 4/10 as well as a mild headache. Felt nauseous throughout the 4/10-4/11 weekend, and experienced odd stool during this time as well.
Numbness in hands and legs, chest tightness, dizziness, difficulty breathing (very mild)
7 days p/vax pt started having fever & jerking motions;cont for 2 days;went to PCP 1st day & hosp admission 2nd day;phenobarb was started in hosp & no further episodes occurred;
pain in the injection site; muscle soreness around the injection site area; Persistent pain; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 9K4T4, expiry date 8th October 2022) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On 31st January 2021, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site pain, injection site muscle pain and pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved and the outcome of the injection site muscle pain and pain were unknown.   It was unknown if the reporter considered the injection site pain, injection site muscle pain and pain to be related to Shingrix.  Additional details were reported as follows: The age of vaccination was not reported. The patient received 2nd dose of Shingrix and still had pain in the injection site referred as muscle soreness around the injection site area. The reporter inquired about the persistent pain post Shingrix administration. The reporter did not consent to follow up.
Sore arm at injection site almost immediately and slight swelling around the area, which I noticed a few hours after the vaccination.
Parents report fever of 102.9 F starting the morning after (1/5/13) MMR administration. Fever of 100-101 lasted for 4 days. Treated with supportive measures. Pt did report dry cough as well.
HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 27-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious
Patient called very upset and stated she has been sick as a dog since she received the shot. Said she was forced to get shot and she had read online where she got sick. Told patient to seek medical attention if she didn't feel well.
Information has been received from a pharmacist and physician's office concerning a 70 year old male with no history of cancer, leukemia or HIV and a history of chickenpox, and unknown shingles history who on 14-JAN-2008 was vaccinated SC with a 0.65 ml dose of Zostavax (Oka/Merck) (lot# 658397/1820U) in the right arm.  The patient had no prednisone or immunosuppressive products noted.  On 21-JAN-2008 the patient developed shingles.  On 29-JAN-2008 the patient contacted the pharmacist to inform him that he was diagnosed with shingles located on his arm.  The pharmacist contacted the physician's office to confirm the shingles diagnosis, which was located on the patient's abdomen, not the arm.  The outcome was unknown.  There was no product quality complaint.  Additional information has been requested.
(R) deltoid showed swelling & redness measuring 17 cm long, 8 cm wide. Pt was advised TYLENOL/MOTRIN 400mg bid for pain & swelling. Also advised to use ice pack for swelling.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. Medical history, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with a second dose of VAQTA (dose, route, site of administration, lot #, expiration date not reported). No concomitant medications were reported. The nurse reported that the patient received a second dose of VAQTA 4 days before the recommended 6 months interval (date unspecified). No adverse effect reported. Additional information has been requested.
Severe fatigue (4/13). Severe fatigue (4/14). Rash (prickly heat, raised bump, extensive rash left side of body down into groin) (4/14/18). Still lingering on 4/24/18. Prescribed loratadine and prednisone.
Body aches, chills, headache, dizziness, ringing in the ears, nausea, vomiting, and fatigue
Headache and intermittent shooting head pains.  Neck pain, pain throughout the spine. Pain behind the eyes.  Pain in the rib cage at various locations.  This pain has been there for one week at the time of this writing.
7 days after the 1st dose of the covid Pfizer vaccine, I developed symptoms at the injection site on my left arm that included mild tenderness, moderate itchiness, severe swelling, and severe erythema. At the start the swelling was approximately 6.5cmx 7cm. We drew a circle around the swelling and by the end of my shift (12 hours later) the swelling and redness at exceeded the original circle we drew. I had no other symptoms systemically, only at the injection site.
WITHIN AN HOUR MY WIFE STARTED THROWING UP AND HAD DIAREHEA
20min p/vax pt devel urticaria rash on both pruritus,dyspnea;rx by squad DPH & Epi, Solumedrol;
Fever, terrible back  pain, chills and nausea first two days.  Could only taste salt.  Injection site pink, swollen and hot.  This lasted two days (Friday and Saturday).  Sunday I had no temp, back pain and nausea.  Still could only taste salt.  Injection site same but starting to itch.  Had trouble walking, dizzy and out of breath.  Monday I was very tired and injection site same.  At this point, I am trying to take limited walks.  Injection site still itches and is still pink but shrinking in size.  I am still very tired.  But each day gets better.
Initial information received on 10-Oct-2018 regarding an unsolicited non valid case non-serious case received from a nurse. Case has been identified as non case as no specific event has been reported. On additional information was received on 02-Nov-2018, the case was considered as valid due to specific event was reported. This case is linked to cases 2018SA284495 and 2018SA284522. This case involves Adult male patient for whom vaccines were given before they were known to be inactive due to temperature stability was reported, while he received vaccine PENTACEL. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 02-Oct-2018, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via intramuscular route in the Right Vastus Lateralis. On an unknown date, patient was given a vaccine which were given before they were known to be inactive due to temperature stability. Unknown latency following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE. All the patients were contacted and no patients reported any adverse events to be inactive vaccines. Final diagnosis was vaccines were given before they were known to be inactive due to temperature stability. It was an actual medication error due to incorrect product storage. Outcome of the event was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none. Additional information was received on 02-Nov-2018. Event was updated. The case was considered as valid.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' pertinent medical histories, concomitant medications and drug reactions or allergies reported. On an unknown dates, the patients were vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot# L003227, expiration date 13-OCT-2016, dose, anatomical location and route of administration were not reported). No adverse event reported. There was no temperature excursion. The time frame was 11.7 Celsius degree for 1 hour, 30 minutes; -1 Celsius degree for 2 hours, 50 minutes; 11.6 Celsius degree for 4 hours, 20 minutes and -2.3 Celsius degree for 63 hours, 10 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
Heavy diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Heavy diarrhea) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR), APIXABAN and LOPERAMIDE HYDROCHLORIDE (IMODIUM) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIARRHOEA (Heavy diarrhea). At the time of the report, DIARRHOEA (Heavy diarrhea) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
She cares for her  87 yr. old mother who had the first vax and she is asking if it is excreted in stool because she changes her poopy diapers.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A 87 year-old female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "blood disorder" (unspecified if ongoing), notes: Rare blood disorder; "spleen removed" (unspecified if ongoing), notes: Spleen removed when she was young and was told not to get live vaccinations. The patient's concomitant medications were not reported.  The following information was reported: ABNORMAL FAECES (non-serious) with onset 2021, outcome "unknown", described as "She cares for her 87 yr. old mother who had the first vax and she is asking if it is excreted in stool because she changes her poopy diapers.".  Additional information: After call she mentioned her mother received vax 30 days ago.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
not received a second dose.; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (not received a second dose.) and NAUSEA (Nauseous) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced NAUSEA (Nauseous). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (not received a second dose.). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. On 12-Mar-2021, NAUSEA (Nauseous) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (not received a second dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Reporter did not allow further contact
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: itching redness and swelling is spreadimg-Mild, Systemic: Flushed / Sweating-Mild
Area surrounding injection site red and swollen; slightly itchy, "but only after reading about the potential reaction symptoms" (her words). Claims to have no negative reactions to the first two of the main series of Moderna, nor to the first Booster. Pt described as not noticing until "this morning" when "she woke up after sleeping on it." Claims it was only sore "because [she] slept on it." No limited range of movement, fever, aches, chills, nor dizziness. Was concerned about reaction, so returned to the pharmacy to "get checked out."  Not technically a clinic, so marked as "none of the above" for Outcomes. Patient is still actively swollen, thus pt has not recovered yet from the adverse event, but is expected to.
Patient was due for MMR and Varicella vaccine. Patient was too old for combination MMRV vaccine, so plan was to administer MMR and standalone Varicella. Patient was given Varicella vaccine without issue. When preparing MMR for administration, the following error occurred: Vaccine pulled from freezer bin labeled "MMR". Vaccine in bin was actually MMRV. Nurse who pulled from bin did not check vial, and nurse who drew up vaccine also did not check vial. Mistake was noted when lot numbers were being verified by office staff for entry into record system. Pts mother was informed of the error and was understanding. Patient and parent were given overview of sheet for Varicella and MMRV. Monitored for 10 minutes by staff for adverse reaction. Advised parent and patient of adverse reactions to look out for at home. Patient and parent discharged home without incident.
Ear ringing; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 13:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. The patient did not receive other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 00:00, the patient experienced ear ringing persistent, low level, and cyclical in pitch, but very noticeable. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event ear ringing was not resolved at the time the report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Between 4:30 and 5:15 I was going to my sons house and about 10 mins before I got there my mouth went numb-I was trying to talk to my husband and my words were slurring like I had a lot to drink. Lasted about 10-12 mins.
Covid-19 positive test results; Covid-19 positive test results; This is a spontaneous report from a contactable consumer. A 51-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: ER8729), via intramuscular route on 09Apr2021 as dose 2, single (at the age of 51 years) and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6203), via intramuscular route on 16Mar2021 as dose 1, single (at the age of 51 years), for covid-19 immunization. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was stated that, on 03Aug2021, the patient had Covid-19 positive test results. The adverse event resulted Doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 via PCR test via Nasal Swab sample taken on 01Aug2021, which came out to be positive. No treatment was received. The outcome for the event was recovering at the time of report.  Follow-up attempts are completed. No further information is expected.
Vaccine was expired at time of administration.  It was past bud of 10 weeks in the fridge.  It expired on 3/30/22.  Called patient to discuss cdc recommendation for re-vaccination.  Patient did schedule appointment for re-vax.
Severe dizziness; Ringing in ears; Brain fog; Trouble concentrating; Fatigue; Nausea; Headaches; Tingling in fingers; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 04 Mar2021 at 09:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient previously took trimethobenzamide hydrochloride (TIGAN) and experienced drug allergy. On 25Mar2021 the patient experienced severe dizziness, ringing in ears, brain fog, trouble concentrating, fatigue, nausea, headaches, tingling in fingers and swollen lymph nodes. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe dizziness, ringing in ears, brain fog, trouble concentrating, fatigue, nausea, headaches, tingling in fingers and swollen lymph nodes was not resolved at the time of this report. . No follow-up attempts are needed. No further information is expected .
doses administered past the published expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date). On 26-Oct-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   it was reported that vaccine was removed from freezer at 8 am on 26-OCT-2021  No concomitant medication details was provided. No treatment medication details was provided.
CLIENT HAD SYNCOPE REACTION ABOUT 12-15 MINUTES AFTER ADMINISTRATION OF ALL VACCINES.
Thigh swelling and redness. Benadryl / Ice, Clindamycin
Pulled up 0.3 ml of air to inject into vial to pull up the vaccine. Instead of putting the needle in the vial, I never drew up the vaccine and injected 0.3 ml of air into patient's muscle. After realizing it felt different. Examined that there was an extra dose in the Pfizer bivalent vial, and no residue in the syringe used to inject pt. It was determined that she just received air. Talked with patient and explained the situation, she felt that she didn't receive the vaccine either so we proceeded to repeat the process and give the vaccine. Patient didn't have any symptoms, signs of symptoms.
Redness and tenderness at injection site 2 days after vaccine was given. PE =  5 x 5 cm erythema well demarcated rash at injection site.
Tested positive for COVID 02/21/22. Headache and congestion, coughing. The symptoms weren't bad. It's hard to tell how long they lasted because I've been sick since I got COVID. Mostly has been chronic nausea which can't get over. Now there is a constant bitter taste in my mouth, and everything tastes like poison, I've had light-headiness, my finger and patch on my face on a scar I had surgery on turned blue whenever I'm cold. I've had chills for a long while.
Patient given 1 ml instead of the 0.5 ml dose of the vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Patient given 1 ml instead of the 0.5 ml dose of the vaccine.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient given 1 ml instead of the 0.5 ml dose of the vaccine.). On 12-Mar-2021, ACCIDENTAL OVERDOSE (Patient given 1 ml instead of the 0.5 ml dose of the vaccine.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information and Treatment information not provided by the reporter.
I started having cramps in my belly after the 1st dosage that carried over to the 2nd dosage. I started having panic attacks and shakiness in my arms along with lose of weight (no appetite whatsoever). It has been like that every since and then the insomnia following the 2nd dosage and I had a feeling of bloating after I ate anything, became restless, sweating a lot, vision was blurry, and noticeable changes in my stool (became yellowish). I been gasping for air after any physical activity or eating. I also noticed that the mucus is yellowish in my throat and tongue. I also experience muscle cramps when attempting to fall asleep which causes me to wake up instantly (also happens when I eat...legs and arms start twitching). If I try to swallow, the yellowish mucus wakes me up while I am trying to sleep. The symptoms started gradually and I didn't have anything of them prior to taking either dosage of the vaccine. The emergency medical team did some tests upon arriving at my home to see if I needed to be transported to the hospital (was not necessary since my heart was working fine).
Patient informs us that first shot was given in the back of her arm subcutaneously instead of IM as a result causing more pain. Patient informed shot is still effective given route of administration.